|
| Effectif (N = 400) | Pourcentage (%) |
| Symptomatic therapy |
|
|
| Loop diuretic | 377 | 94.25 |
| thiazidic | 223 | 55.75 |
| Molsidomine | 88 | 22.00 |
| Digoxine | 56 | 14.00 |
| Dobutamine | 18 | 04.50 |
| Dopamine | 8 | 02.00 |
| Prognostic therapy |
|
|
| Lifestyle | 324 | 81.00 |
| RAAS inhibitors | 330 | 82.50 |
| Beta-blockers | 229 | 57.25 |
| MRA | 168 | 42.00 |
| Other therapy |
|
|
| Antithrombotics | 323 | 80.75 |
| Antibiotics | 151 | 37.75 |
| Iron | 81 | 20.25 |
| Anti-malaria | 66 | 16.50 |
| Antiarrhythmics | 39 | 09.75 |
| Analgesics | 34 | 08.50 |
| Potassium supplementation | 358 | 89.50 |
| Hypouricemics | 54 | 13.50 |
| Statins | 40 | 10.00 |
| Anxiolytics | 36 | 09.00 |
| Therapeutic observance | ||
| Good | 112 | 28.00 |
| Bad | 288 | 72.00 |